Covered recipient · General Payments record
TIPU FAIZ MUHAMMAD SALEEM
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$154,844.76
- Reported across 263 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.65 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $207.11 | 6 |
| Acerta Pharma LLC | $92.48 | 1 |
| IBSA Pharma Inc. | $74.26 | 3 |
| Tandem Diabetes Care, Inc. | $63.00 | 1 |
| Acella Pharmaceuticals, LLC | $44.42 | 2 |
| Ascendis Pharma Inc | $29.35 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.73 | 1 |
| Averitas Pharma Inc. | $19.68 | 1 |
| BETA BIONICS, INC. | $4.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acella Pharmaceuticals, LLC | $21.04 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126636888 | CMS |
| Acella Pharmaceuticals, LLC | $23.38 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126636890 | CMS |
| Amgen Inc. | $12.97 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081723 | CMS |
| Amgen Inc. | $16.74 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081743 | CMS |
| Amgen Inc. | $124.99 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081716 | CMS |
| Amgen Inc. | $18.06 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081729 | CMS |
| Amgen Inc. | $24.22 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081749 | CMS |
| Amgen Inc. | $10.13 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081735 | CMS |
| Ascendis Pharma Inc | $29.35 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133849834 | CMS |
| AstraZeneca Pharmaceuticals LP | $92.48 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104427769 | CMS |
| Averitas Pharma Inc. | $19.68 | 11/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133444429 | CMS |
| BETA BIONICS, INC. | $4.62 | 12/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087890353 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.73 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117920411 | CMS |
| IBSA Pharma Inc. | $24.99 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984828 | CMS |
| IBSA Pharma Inc. | $24.56 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984830 | CMS |
| IBSA Pharma Inc. | $24.71 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984832 | CMS |
| Tandem Diabetes Care, Inc. | $63.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138739777 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.